Dr. Peter Kash is a co-founder and Vice-Chairman of TargImmune Therapeutics (Switzerland). He was formerly a co-founder and partner and Chairman of Two River Group and President of Riverbank Capital Securities specializing in creating and financing several biotech companies including Kite Pharma, Edgemont Pharmaceuticals, and Intercept Pharmaceuticals. He has cofounded more than a dozen biotech...
Dr. Colby Kash is the Chief Executive Officer and co-founder of Camelot BioCapital, a biotechnology venture studio and advisory firm focused on advancing innovative technologies that increase the human healthspan. As a leader in the field, Dr. Kash directs a team of more than 15 professionals, including physicians, scientists, and investment experts, in developing and...
Mr. Matthew Bronfman is the Chairman and CEO of BHB Holdings, a private investment firm with numerous interests. He served as Chairman of Bronfman Rothschild, a Washington, D.C. based Registered Investment Advisor. In addition, Mr. Bronfman controls the IKEA franchise in Israel and has numerous real estate holdings there and in the U.S. He also...
Dr. Josh Sharan is a distinguished physician-scientist with deep expertise in drug development and therapeutic venture capital. As the Chief Scientific Officer at Camelot BioCapital, Dr. Sharan leads the identification and evaluation of promising therapeutic candidates, overseeing technical diligence and acquisition efforts to drive innovation in the biotech landscape. Dr. Sharan is also a co-founder...
Dr. Friedland is a physician with over 25 years of experience in clinical medicine and an international advisor to many Fortune and Forbes global companies. She consults with healthcare, biotech, corporate, and financial institutions. Among her roles, Dr. Friedland is the head of Business Development at Firebrick Pharma (Australia), senior consultant to TargImmune Therapeutics (Basel,...
Dr. Rice graduated with honors from Nova Southeastern University’s College of Osteopathic Medicine. As Vice President, with a background in both business and healthcare, Dr. Rice is responsible for identifying and pursuing new business opportunities. He assists all C-suite personnel and spends much of his focus in the preclinical and clinical development of the company’s...
Mr. Veerappan is a seasoned entrepreneur, investor, and executive with over two decades of experience across the pharmaceutical, technology, media, and finance sectors. He currently serves as Chairman and CEO of Sapphire Pharma LLC, a pharmaceutical company focused on strategic innovation, and is the Founder and Principal of Tydings Capital LLC, a private investment firm....
Joe LeBas is the President, Managing Director, and Founder of Concorde Group Holdings, LLC, a global, technology-driven commercial real estate (CRE) development firm that owns nearly 1 million square feet of commercial retail, office, industrial, and executive housing assets across the Southeastern United States, United Arab Emirates, and India. Mr. LeBas is an accomplished technology...
Dr. Banks is a 25-year veteran of the pharmaceutical industry with a proven record of clinical, regulatory, and entrepreneurial success. Dr. Banks has served as a drug development expert, corporate R&D adviser, company creator, and venture-capital adviser to more than 350 pharmaceutical and biotechnology companies (from start-ups to multinationals). He has contributed to the successful...
Tomer is the Israeli General Partner at Camelot BioCapital. He is a serial entrepreneur and venture builder specializing in healthcare, biotech, and deep tech innovation. His first equity deal was with NYX Technologies, a leading neuroscience tech company he co-founded in 2016, where he has served as CEO and chairman since its inception. Prior to...